Clinical Trial Update: Vaccine Responses in Patients With B Cell Malignancies [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial is evaluating vaccine responses in patients with B cell malignancies, including lymphoma, and is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lymphoma

Snippet

Sponsor: National Heart, Lung, and Blood Institute (NHLBI) | Conditions: Lymphoma | Phase 4 | Status: RECRUITING